Niranjan B. Pandey
14Patents
3h-index
23Co-inventors
56Inventor score
Filing activity: Sep 15, 2005 → Aug 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7579356B2 | Thia-tetraazaacenaphthylene kinase inhibitors | Human Necessities | 9 | Expired |
| US8299017B2 | Use of tight junction antagonists to treat inflammatory bowl disease | Chemistry; Metallurgy | 6 | Active |
| US8796203B2 | Use of tight junction antagonists to treat inflammatory bowel disease | Chemistry; Metallurgy | 4 | Active |
| US7605154B2 | Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors | Human Necessities | 2 | Active |
| US9056923B2 | Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases | Chemistry; Metallurgy | 1 | Active |
| US10106597B2 | Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases | Chemistry; Metallurgy | 1 | Active |
| US9802984B2 | Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases | Chemistry; Metallurgy | 1 | Active |
| US11155603B2 | Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases | Chemistry; Metallurgy | 0 | Active |
| US11674959B2 | Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptors | Physics | 0 | Active |
| US11981754B2 | Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases | Chemistry; Metallurgy | 0 | Active |
| US10774131B2 | Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases | Chemistry; Metallurgy | 0 | Active |
| US10774112B2 | Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases | Chemistry; Metallurgy | 0 | Active |
| US7427625B2 | Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7659284B2 | Thiazolopyridine kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.